3-[4-(3-aminopropoxy)-3-bromophenyl]-2-hydroxyimino-N-[2-(1H-indol-3-yl)ethyl]propanamide hydrochloride

ID: ALA558971

Max Phase: Preclinical

Molecular Formula: C22H26BrClN4O3

Molecular Weight: 473.37

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cl.NCCCOc1ccc(C/C(=N/O)C(=O)NCCc2c[nH]c3ccccc23)cc1Br

Standard InChI:  InChI=1S/C22H25BrN4O3.ClH/c23-18-12-15(6-7-21(18)30-11-3-9-24)13-20(27-29)22(28)25-10-8-16-14-26-19-5-2-1-4-17(16)19;/h1-2,4-7,12,14,26,29H,3,8-11,13,24H2,(H,25,28);1H/b27-20-;

Standard InChI Key:  BFJNITIQXYHKER-HNKVEKQCSA-N

Molfile:  

     RDKit          2D

 31 32  0  0  0  0  0  0  0  0999 V2000
   15.7648    7.0318    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    7.4549   10.3721    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9224   10.6823    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9249    9.5665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4598    8.1405    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9923    7.8301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9898    8.9460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5241    6.4042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0553    6.0958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5870    4.6698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0564    7.2160    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8813    6.9729    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1182    4.3614    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3875    3.7758    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6500    2.9355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1812    2.6271    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6529   11.2647    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    9.3907   12.1083    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.8595   12.4166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3277   13.8425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7966   14.1509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1710   15.2910    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7138    1.2033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7138   -1.2033    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5889    0.0182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2917    0.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0028    1.5132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3155    0.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3155   -0.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0028   -1.5132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2917   -0.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  2  7  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  2  0
 11 12  1  0
 10 13  1  0
 10 14  2  0
 13 15  1  0
 15 16  1  0
  2 17  1  0
  3 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 16 23  1  0
 23 25  2  0
 24 25  1  0
 23 26  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 24 31  1  0
 26 31  2  0
 30 31  1  0
M  END

Associated Targets(Human)

2008 (263 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

L1210 (27553 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Dync1h1 Dynein heavy chain (8 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 473.37Molecular Weight (Monoisotopic): 472.1110AlogP: 3.39#Rotatable Bonds: 10
Polar Surface Area: 112.73Molecular Species: BASEHBA: 5HBD: 4
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 8.77CX Basic pKa: 9.97CX LogP: 2.29CX LogD: 1.18
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.16Np Likeness Score: 0.02

References

1. Zhu G, Yang F, Balachandran R, Höök P, Vallee RB, Curran DP, Day BW..  (2006)  Synthesis and biological evaluation of purealin and analogues as cytoplasmic dynein heavy chain inhibitors.,  49  (6): [PMID:16539395] [10.1021/jm051030l]

Source